α-Fetoprotein

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 4, 2011, Pages 141-147

  Murray, M J ^a,b   Nicholson, J C ^b  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; MICRORNA 21; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AMNIOCENTESIS; BECKWITH WIEDEMANN SYNDROME; CANCER DIAGNOSIS; CEREBROSPINAL FLUID LEVEL; CHORIOCARCINOMA; CHRONIC LIVER DISEASE; DIFFERENTIAL DIAGNOSIS; EMBRYONAL CARCINOMA; ENZYME IMMUNOASSAY; EVENT FREE SURVIVAL; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GERM CELL TUMOR; HEPATOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACRANIAL PRESSURE; LIVER CELL CARCINOMA; LUMBAR PUNCTURE; MALIGNANT TRANSFORMATION; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANT WOMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; REVIEW; SECOND TRIMESTER PREGNANCY; TERATOMA; TREATMENT RESPONSE; YOLK SAC TUMOR;

ALPHA-FETOPROTEINS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL DIAGNOSIS;

EID: 80955180029     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2011.213181     Document Type: Review

References (37)

1. Gitlin D, Perricelli A, Gitlin GM. Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 1972;32:979-82.
2. Law SW, Dugaiczyk A. Homology between the primary structure of alpha-fetoprotein, deduced from a complete cDNA sequence, and serum albumin. Nature 1981;291:201-5.
3. Bélanger L, Roy S, Allard D. New albumin gene 3′ adjacent to the alpha 1-fetoprotein locus. J Biol Chem 1994;269:5481-4.
4. Blohm ME, Vesterling-Hörner D, Calaminus G, et al. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 1998;15:135-42. (Pubitemid 28213543)
5. Nishizono I, Iida S, Suzuki N, et al. Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers. Clin Chem 1991;37:1639-44. (Pubitemid 21905231)
6. Jassam N, Jones CM, Briscoe T, et al. The hook effect: a need for constant vigilance. Ann Clin Biochem 2006;43:314-17. (Pubitemid 44049697)
7. Murray MJ, Nicholson JC. Germ cell tumours in children and adolescents. J Paediatr Child Health 2010;20:109-16.
8. Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 2010;52:252-7.
9. Allen JC, Nisselbaum J, Epstein F, et al. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. J Neurosurg 1979;51:368-74. (Pubitemid 9255012)
10. Nicholson JC, Punt J, Hale J, et al.; Germ Cell Tumour Working Groups of the United Kingdom Children's Cancer Study Group (UKCCSG) and International Society of Paediatric Oncology (SIOP). Neurosurgical management of paediatric germ cell tumours of the central nervous system - a multi-disciplinary team approach for the new millennium. Br J Neurosurg 2002;16:93-5.
11. Mann JR, Gray ES, Thornton C, et al.; UK Children's Cancer Study Group Experience. Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience. J Clin Oncol 2008;26:3590-7.
12. Heifetz SA, Cushing B, Giller R, et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. Am J Surg Pathol 1998;22:1115-24. (Pubitemid 28411070)
13. Grigor KM, Detre SI, Kohn J, et al. Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours. Br J Cancer 1977;35:52-8. (Pubitemid 8018924)
14. Baranzelli MC, Kramar A, Bouffet E, et al. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 1999;17:1212.
15. Calaminus G, Vesterling-Hörner D, Bökkerink JP, et al. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors]. Klin Padiatr 1991;203:246-50.
16. Van Tornout JM, Buckley JD, Quinn JJ, et al. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol 1997;15:1190-7. (Pubitemid 27106307)
17. De Ioris M, Brugieres L, Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 2008;44:545-50.
18. Meyers RL, Rowland JR, Krailo M, et al. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009;53:1016-22.
19. von Schweinitz D, Bürger D, Bode U, et al. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol]. Klin Padiatr 1994;206:282-8.
20. Kosola S, Lauronen J, Sairanen H, et al. High survival rates after liver transplantation for hepatoblastoma and hepatocellular carcinoma. Pediatr Transplant 2010;14:646-50.
21. Gregory JJ Jr, Finlay JL. Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers. Drugs 1999;57:463-7.
22. Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 2006;42:486-90. (Pubitemid 44252516)
23. Everman DB, Shuman C, Dzolganovski B, et al. Serum alphafetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 2000;137:123-7. (Pubitemid 30470935)
24. Clericuzio CL, Chen E, McNeil DE, et al. Serum alphafetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003;143:270-2. (Pubitemid 37082965)
25. Schneider DT, Calaminus G, Göbel U. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood. Pediatr Hematol Oncol 2001;18:11-26. (Pubitemid 32064223)
26. Johnson PJ. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999;14(Suppl):S32-6.
27. Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004;127 (5 Suppl 1):S104-7.
28. Wald NJ, Cuckle H, Brock JH, et al. Maternal serumalpha- fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neuraltube defects. Lancet 1977;1:1323-32. (Pubitemid 8127680)
29. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
30. Wald NJ, Kennard A, Densem JW, et al. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992;305:391-4.
31. Reynolds T. The triple test as a screening technique for Down syndrome: reliability and relevance. Int J Womens Health 2010;2:83-8.
32. Kim TJ, Lee YS, Song YS, et al. Infantile hemangioendothelioma with elevated serum alpha fetoprotein: report of 2 cases with immunohistochemical analysis. Hum Pathol 2010;41:763-7.
33. Germà JR, Llanos M, Tabernero JM, et al. False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer 1993;72:2491-4. (Pubitemid 23299616)
34. Kinoshita Y, Tajiri T, Souzaki R, et al. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study. J Pediatr Hematol Oncol 2008;30:447-50.
35. Palmer RD, Murray MJ, Saini HK, et al.; Children's Cancer and Leukaemia Group. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 2010;70:2911-23.
36. Murray MJ, Halsall DJ, Hook CE, et al. Identification of microRNAs From the miR-371 ∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 2011;135:119-25.
37. Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136-42.